CR

Cancer Research

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal that publishes clinical, translational, and basic research on hepatocellular carcinoma, including signaling pathways, molecular tumor classification, therapies, radiology, epidemiology, surveillance, prevention, and quality of life.

Looking to publish in Cancer Research? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 16.6
Quartile Q1
Open Access Type Open
ISSN 0008-5472
eISSN 1538-7445
Invitation Only No
Cost Range Publication involves a base publication fee and an additional fee for each display item; authors may apply for a waiver of the fixed publication fee if no financial support exists.

Submission Instructions

Cancer Research accepts the following article types. Click on an article type to view submission instructions.

Original Research Articles

Cover Letter Cover letter is strongly encouraged for initial submission. Cover letter must describe how any associated manuscript is related to the current submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the following order: title page, text and references, tables, figure legends, and figures. Manuscript must include a conflict of interest disclosure on the title page, a Data Availability subsection at the end of the Materials and Methods or Methods section titled "Data Availability," an Acknowledgments section including funding and any generative AI or other contributors, and a Code Availability Statement if custom computer code was used.
References References must be numbered in order of first mention in the text, cited in the text by number only, and list all authors if there are 6 or fewer or the first 6 authors followed by et al. if there are more than 6.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequence adjacent to its legend, while supplementary data must be uploaded separately. Each figure must have a legend with a short title sentence and description, multi-panel figures must have labeled panels described in the legend, figure legends must include the number of technical and biological replicates, and tables must have descriptive titles and be numbered with Arabic numerals.
Reformat to Cancer Research using Livewrite Premium

Review Manuscript

Cover Letter Cover letter is strongly encouraged for initial submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the following order: title page, text and references, tables, figure legends, and figures. The manuscript must include a conflict of interest disclosure on the title page, a Data Availability subsection at the end of Materials and Methods, acknowledgments of funding and nonauthor contributors, and declarations of any generative AI use in the acknowledgments or other appropriate section.
References References must be numbered in the order of first mention and cited in the text by number only. List all authors when a reference has 6 or fewer authors, but for more than 6 authors list the first 6 followed by et al.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequence adjacent to its legend, while supplementary data must be uploaded separately. Each figure must have a legend with a short title and description, multi-panel figures must have labeled panels described in the legend, and figure legends must include the number of technical and biological replicates.
Reformat to Cancer Research using Livewrite Premium

Meta-Analysis

Cover Letter Cover letter is strongly encouraged for initial submission. Cover letter must describe how any associated manuscript is related to the current submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the order of title page, text and references, tables, figure legends, and figures. The manuscript must include a conflict of interest disclosure statement on the title page, a Data Availability subsection at the end of the Materials and Methods or Methods section, an acknowledgment of any generative AI or editing services in the Acknowledgments section, and a declaration of any AI-produced material in an appropriate section of the manuscript.
References References must be numbered in order of first mention in the text, cited by number only, and list all authors if there are 6 or fewer or the first 6 authors followed by et al. if there are more than 6.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequence adjacent to its legend, while supplementary data must be uploaded separately. Each table must have a descriptive title and Arabic numeral, and each figure must have a legend with a short title sentence and panel descriptions if applicable.
Reformat to Cancer Research using Livewrite Premium

Systematic Reviews

Cover Letter Cover letter is strongly encouraged for initial submission. Cover letter must describe how any associated manuscript is related to the current submission.
Abstract Abstract is required.
Manuscript Initial submissions do not have strict length restrictions, and the methods section is excluded when calculating manuscript length. Manuscript must be arranged in the following order: title page, text and references, tables, figure legends, and figures. Manuscript must include a conflict-of-interest disclosure statement on the title page, a Data Availability subsection at the end of the Materials and Methods, and a declaration of any generative artificial intelligence or human-assisted editing contribution in the acknowledgments or other appropriate section.
References References must be numbered in order of first mention in the text, cited by number only, and list all authors for references with 6 or fewer authors or the first 6 authors followed by et al. for references with more than 6 authors.
Figures & Tables For initial submission, figures and tables should be included in a single manuscript file with each figure presented in sequential order adjacent to its legend, while supplementary data must be uploaded separately. Each table must have a descriptive title and Arabic numeral, and each figure must be cited in order and accompanied by a legend that identifies all panels, symbols, and replicate numbers.
Reformat to Cancer Research using Livewrite Premium

Recent Publications

Virtual Tumors Enable Prediction of Personalized Therapeutic Combinations for Non-Small Cell Lung Cancer

Matthew A. Clarke, Charlie George. Barker, Ashley Nicholls, Matt P. Handler, Lisa Pickard, Amna Z. Shah, David Walter, Etienne De Braekeleer, Udai Banerji, Jyoti S. Choudhary, Saif S. Ahmad, Ultan McDermott, Gregory J. Hannon, Jasmin Fisher

10.1158/0008-5472.can-25-2476
View Publication

Opportunities to enhance cancer research through advocate-researcher partnerships

Sarah B. Gitto, Savannah Hughes, Marcie Paul, Sadhana Bom, Rebecca Burchett, Brian G. Morreale, Abbe Pannucci, Catherine Rono, Christoph Weigel, Cody L. Wolf, James E. Williams, Wendy Cohn, Heather M. Gibson, Sepideh Dolatshahi, Ajay Gupta, Melanie R. Rutkowski, Kristin G. Anderson

10.1158/0008-5472.can-26-1080
View Publication

Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia

David E. Frankhouser, Dandan Zhao, Yu-Hsuan Fu, Anupam Dey, Ziang Chen, Jihyun Irizarry, Jennifer Rangel Ambriz, Tiffany Kanesa Ybarra, Sergio Branciamore, Denis O'Meally, Ryan S. Sathianathen, Jeffrey M. Trent, Stephen J. Forman, Adam L. MacLean, Ya-Huei Kuo, Kathleen M. Sakamoto, Bin Zhang, Russell C. Rockne, Guido Marcucci

10.1158/0008-5472.can-25-4371
View Publication

EGFR N-Glycosylation Catalyzed by NDST2 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma

Huiying Gu, Fan Li, Yuyan Chen, Mengling Zhang, Qiumin Wu, Haibei Zhao, Chongyang Zhou, Li Yan, Ruixi Xie, Xinchang Huang, Jihua Ren, Shengtao Cheng, Haibo Yu, Yong Chen, Zhenzhen Zhang, Juan Chen

10.1158/0008-5472.can-25-4582
View Publication

Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones

Mariam Mathew. George, Linda Hamadene, Yacine Marouf, Nicholas Ceglia, Daniel Hirschhorn, Isabell Schulze, Lauren Dong, Divya Venkatesh, Rachana R. Maniyar, Sadna Budhu, Alan N. Houghton, Benjamin D. Greenbaum, Jedd D. Wolchok, Allison S. Betof, Taha Merghoub

10.1158/0008-5472.can-25-3863
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A cover letter is strongly encouraged for initial submission.

Reformat to Cancer Research using Livewrite Premium

What are the publication costs?

Publication involves a base publication fee and an additional fee for each display item. Authors may apply for a waiver of the fixed publication fee if no financial support exists.

Reformat to Cancer Research using Livewrite Premium

Research Topics

Cancer Genomics and Diagnostics Cancer, Hypoxia, and Metabolism RNA modifications and cancer Cancer Research and Treatments Cancer Immunotherapy and Biomarkers Cancer Cells and Metastasis Cancer-related Molecular Pathways Advanced Breast Cancer Therapies Cancer-related molecular mechanisms research Breast Cancer Treatment Studies Epigenetics and DNA Methylation Monoclonal and Polyclonal Antibodies Research Cancer, Lipids, and Metabolism HER2/EGFR in Cancer Research Immunotherapy and Immune Responses Ferroptosis and cancer prognosis Prostate Cancer Treatment and Research CAR-T cell therapy research Cancer Treatment and Pharmacology Lung Cancer Treatments and Mutations Estrogen and related hormone effects Ubiquitin and proteasome pathways Nanoplatforms for cancer theranostics Protein Degradation and Inhibitors Molecular Biology Techniques and Applications

Related Journals

Ne
Neoplasia Elsevier BV
BC
BMC Cancer BioMed Central
SC
Supportive Care in Cancer Springer Science+Business Media
MC
Molecular Cancer Therapeutics American Association for Cancer Research
MO
Molecular Oncology Elsevier BV
BC
Blood Cancer Journal Springer Nature